secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001372514-24-000010
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals announces $15M private placement with potential $30M from warrant exercises
--------------------------------------------------------------------------------

- Upfront gross proceeds of $15M from sale of shares and pre-funded warrants at $0.5524 per unit.
- Tranche A warrants (24.7M shares, $0.6076 exercise) tied to KIO-301 Phase 2 data; Tranche B tied to KIO-104 Phase 2.
- Participating investors include ADAR1 Capital, Nantahala Capital, Rosalind Advisors, Stonepine Capital, Velan Capital.
- Net proceeds to fund KIO-104 development for posterior non-infectious uveitis and general operations.
- Closing expected on or about February 5, 2024, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000010/0001372514-24-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000010/kprx-20240131.htm
  HTML page:      https://secwatch.observer/filing/0001372514-24-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer